_id
6914847fccc777a4e85d9508
Ticker
NTHI
Name
NeOnc Technologies Holdings, Inc. Common Stock
Exchange
NASDAQ
Address
23975 Park Sorrento, Calabasas, CA, United States, 91302
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.neonc.com
Description
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary brain tumors. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. NeOnc Technologies Holdings, Inc. was incorporated in 2005 and is headquartered in Calabasas, California.
Last Close
8.47
Volume
28795
Current Price
10
Change
0.61
Last Updated
2026-01-05T11:44:39.462Z
Image
data:image/webp;base64,UklGRkIBAABXRUJQVlA4IDYBAADwCwCdASpAAEAAPrVMoEynI6MiKBQNUOAWiWkA09h7b8MIPxVnYfWdqnQX/n57ZPjVxkPa8+9hiOVdLrP9q+b+U7d8xJjaZ2RqO1mCihcQ4LlO2jmoniAOk/iSbiYd9H4hetKNzkGAYAD+/nrXMgxJsgxPQkUn32nOMez93pv4BJ9NVyNc+Awewh7hOwEl9hJCcit99jp6/+mEsyDlzCTTlj9nSgDMdIo5X8lOsbF5zYEZlS21HLKW7JdntGzCVBtrTOY8aApxXFlAuadrKzpsJhP2Rc5uIpBO3gWYZovFQEfcFKwOixI/76/n8KizM4G65K5SR6YeWi/WDl1/EyaKHTJ0UO9TtuznCIB4guOhdnlI0vRO9U0G4HJFuzesiDy4/JKf1DkVQ24jF1TMndyVFd6rLAAA
Ipo Date
2025-03-26T00:00:00.000Z
Market Cap
90757832
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
6934647
Operating Income
-6934647
Interest Expense
869815
Pretax Income
-8615920
Net Income
-8615920
Eps
-0.4484714949110557
Dividends Per Share
-
Shares Outstanding
19026800
Income Tax Expense
-
EBITDA
-7635927
Operating Margin
-
Total Other Income Expense Net
-1681273
Cash
1513224
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
2961576
Property Plant Equipment
379509
Total Assets
4082916
Payables
499900
Short Term Debt
69877
Long Term Debt
-
Total Liabilities
15897186
Equity
-11814270
Bs_currency_symbol
USD
Depreciation
110178
Change In Working Capital
-628276
Cash From Operations
-5808551
Capital Expenditures
5
Cash From Investing
-
Cash From Financing
7196736
Net Change In Cash
1388185
Cf_currency_symbol
USD
PE
-
PB
-16.261474471126867
ROE
72.92807765524235
ROA
-211.02368993141178
FCF
-5808556
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
6934647
Quarters > 0 > income Statement > operating Income
-6934647
Quarters > 0 > income Statement > interest Expense
869815
Quarters > 0 > income Statement > pretax Income
-8615920
Quarters > 0 > income Statement > net Income
-8615920
Quarters > 0 > income Statement > eps
-0.4484714949110557
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
19211745
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7635927
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1681273
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1513224
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2961576
Quarters > 0 > balance Sheet > property Plant Equipment
379509
Quarters > 0 > balance Sheet > total Assets
4082916
Quarters > 0 > balance Sheet > payables
499900
Quarters > 0 > balance Sheet > short Term Debt
69877
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
15897186
Quarters > 0 > balance Sheet > equity
-11814270
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-8615920
Quarters > 0 > cash Flow > depreciation
110178
Quarters > 0 > cash Flow > change In Working Capital
-628276
Quarters > 0 > cash Flow > cash From Operations
-5808551
Quarters > 0 > cash Flow > capital Expenditures
5
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
7196736
Quarters > 0 > cash Flow > net Change In Cash
1388185
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.4484714949110557
Quarters > 0 > ratios > PB
-16.261474471126867
Quarters > 0 > ratios > ROE
72.92807765524235
Quarters > 0 > ratios > ROA
-211.02368993141178
Quarters > 0 > ratios > FCF
-5808556
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
5708034
Quarters > 1 > income Statement > operating Income
-5708034
Quarters > 1 > income Statement > interest Expense
240999
Quarters > 1 > income Statement > pretax Income
-5680170
Quarters > 1 > income Statement > net Income
-5680170
Quarters > 1 > income Statement > eps
-0.29853560056627565
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
19026776
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-5708034
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
27864
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
125039
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
148705
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1653942
Quarters > 1 > balance Sheet > property Plant Equipment
397817
Quarters > 1 > balance Sheet > total Assets
2988187
Quarters > 1 > balance Sheet > payables
3572860
Quarters > 1 > balance Sheet > short Term Debt
137266
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
14803681
Quarters > 1 > balance Sheet > equity
-11815494
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4199
Quarters > 1 > cash Flow > depreciation
210402
Quarters > 1 > cash Flow > change In Working Capital
-7772719
Quarters > 1 > cash Flow > cash From Operations
-5314171
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-5314171
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.29853560056627565
Quarters > 1 > ratios > PB
-16.10324206503765
Quarters > 1 > ratios > ROE
48.07391040950129
Quarters > 1 > ratios > ROA
-190.0875012172933
Quarters > 1 > ratios > FCF
-5314171
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
39990
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
39990
Quarters > 2 > income Statement > operating Expenses
37616803
Quarters > 2 > income Statement > operating Income
-37576813
Quarters > 2 > income Statement > interest Expense
476873
Quarters > 2 > income Statement > pretax Income
-38001987
Quarters > 2 > income Statement > net Income
-38001987
Quarters > 2 > income Statement > eps
-2.095468582104189
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
18135317
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-37693065
Quarters > 2 > income Statement > operating Margin
-93965.52388097024
Quarters > 2 > income Statement > total Other Income Expense Net
-425174
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5439210
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
7360191
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
8441691
Quarters > 2 > balance Sheet > payables
4143255
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
18065336
Quarters > 2 > balance Sheet > equity
-9623645
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-38001987
Quarters > 2 > cash Flow > depreciation
877192
Quarters > 2 > cash Flow > change In Working Capital
8400995
Quarters > 2 > cash Flow > cash From Operations
-5650055
Quarters > 2 > cash Flow > capital Expenditures
5
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
11024372
Quarters > 2 > cash Flow > net Change In Cash
5374317
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.095468582104189
Quarters > 2 > ratios > PB
-18.844540711965163
Quarters > 2 > ratios > ROE
394.88143006106316
Quarters > 2 > ratios > ROA
-450.1703154024472
Quarters > 2 > ratios > FCF
-5650060
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-141.28682170542635
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
20000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
20000
Quarters > 3 > income Statement > operating Expenses
2133732
Quarters > 3 > income Statement > operating Income
-2113732
Quarters > 3 > income Statement > interest Expense
142696
Quarters > 3 > income Statement > pretax Income
-2252982
Quarters > 3 > income Statement > net Income
-2252982
Quarters > 3 > income Statement > eps
-0.12018554491883944
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
18745865
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2188307
Quarters > 3 > income Statement > operating Margin
-10568.66
Quarters > 3 > income Statement > total Other Income Expense Net
-139250
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
64893
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
148705
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2195203
Quarters > 3 > balance Sheet > property Plant Equipment
23526
Quarters > 3 > balance Sheet > total Assets
3417241
Quarters > 3 > balance Sheet > payables
3521356
Quarters > 3 > balance Sheet > short Term Debt
24722
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
8922202
Quarters > 3 > balance Sheet > equity
-5504961
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2252982
Quarters > 3 > cash Flow > depreciation
67076
Quarters > 3 > cash Flow > change In Working Capital
1087591
Quarters > 3 > cash Flow > cash From Operations
-954404
Quarters > 3 > cash Flow > capital Expenditures
4
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-315330
Quarters > 3 > cash Flow > net Change In Cash
-1269734
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.12018554491883944
Quarters > 3 > ratios > PB
-34.052675395883824
Quarters > 3 > ratios > ROE
40.92639348398654
Quarters > 3 > ratios > ROA
-65.92985393772345
Quarters > 3 > ratios > FCF
-954408
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-47.7204
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
83000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
83000
Annuals > 0 > income Statement > operating Expenses
7225522
Annuals > 0 > income Statement > operating Income
-7142522
Annuals > 0 > income Statement > interest Expense
2702152
Annuals > 0 > income Statement > pretax Income
-11898464
Annuals > 0 > income Statement > net Income
-11898464
Annuals > 0 > income Statement > eps
-0.6347247246259375
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
18745865
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-9095464
Annuals > 0 > income Statement > operating Margin
-8605.448192771084
Annuals > 0 > income Statement > total Other Income Expense Net
-4755942
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
64893
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
148705
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2195203
Annuals > 0 > balance Sheet > property Plant Equipment
23526
Annuals > 0 > balance Sheet > total Assets
3417241
Annuals > 0 > balance Sheet > payables
3521356
Annuals > 0 > balance Sheet > short Term Debt
49444
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8922202
Annuals > 0 > balance Sheet > equity
-5504961
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11898464
Annuals > 0 > cash Flow > depreciation
245945
Annuals > 0 > cash Flow > change In Working Capital
1486339
Annuals > 0 > cash Flow > cash From Operations
-4213916
Annuals > 0 > cash Flow > capital Expenditures
4
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
4246947
Annuals > 0 > cash Flow > net Change In Cash
33031
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.6347247246259375
Annuals > 0 > ratios > PB
-30.238775751544836
Annuals > 0 > ratios > ROE
216.14075013428797
Annuals > 0 > ratios > ROA
-348.189197074482
Annuals > 0 > ratios > FCF
-4213920
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-50.77012048192771
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
70462
Annuals > 1 > income Statement > cost Of Revenue
2737773
Annuals > 1 > income Statement > gross Profit
70462
Annuals > 1 > income Statement > operating Expenses
12268131
Annuals > 1 > income Statement > operating Income
-12197669
Annuals > 1 > income Statement > interest Expense
2723396
Annuals > 1 > income Statement > pretax Income
-14921065
Annuals > 1 > income Statement > net Income
-14921065
Annuals > 1 > income Statement > eps
-0.7959656702958225
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
18745865
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-12197669
Annuals > 1 > income Statement > operating Margin
-17310.98890181942
Annuals > 1 > income Statement > total Other Income Expense Net
-2723396
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
31862
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1265376
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
1265376
Annuals > 1 > balance Sheet > payables
2956929
Annuals > 1 > balance Sheet > short Term Debt
6605457
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
15253629
Annuals > 1 > balance Sheet > equity
-13988253
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-14921065
Annuals > 1 > cash Flow > depreciation
0
Annuals > 1 > cash Flow > change In Working Capital
1713758
Annuals > 1 > cash Flow > cash From Operations
-1880012
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1278576
Annuals > 1 > cash Flow > net Change In Cash
-601436
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.7959656702958225
Annuals > 1 > ratios > PB
-11.900219505609458
Annuals > 1 > ratios > ROE
106.6685382370479
Annuals > 1 > ratios > ROA
-1179.1803384922741
Annuals > 1 > ratios > FCF
-1880012
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-26.681218245295337
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
20000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
20000
Annuals > 2 > income Statement > operating Expenses
2857604
Annuals > 2 > income Statement > operating Income
-2837604
Annuals > 2 > income Statement > interest Expense
200153
Annuals > 2 > income Statement > pretax Income
-3046757
Annuals > 2 > income Statement > net Income
-3046757
Annuals > 2 > income Statement > eps
-0.16252954985006027
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
18745865
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-2846604
Annuals > 2 > income Statement > operating Margin
-14188.02
Annuals > 2 > income Statement > total Other Income Expense Net
-209153
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
633298
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
728682
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
728682
Annuals > 2 > balance Sheet > payables
1341593
Annuals > 2 > balance Sheet > short Term Debt
50000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2304093
Annuals > 2 > balance Sheet > equity
-1575411
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3046757
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
666221
Annuals > 2 > cash Flow > cash From Operations
-881736
Annuals > 2 > cash Flow > capital Expenditures
4
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1490000
Annuals > 2 > cash Flow > net Change In Cash
608264
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.16252954985006027
Annuals > 2 > ratios > PB
-105.66339907490807
Annuals > 2 > ratios > ROE
193.39442215396488
Annuals > 2 > ratios > ROA
-418.1188776448437
Annuals > 2 > ratios > FCF
-881740
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-44.087
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
3271683
Annuals > 3 > income Statement > operating Income
-3271683
Annuals > 3 > income Statement > interest Expense
112919
Annuals > 3 > income Statement > pretax Income
-3375602
Annuals > 3 > income Statement > net Income
-3375602
Annuals > 3 > income Statement > eps
-0.18007181850504098
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
18745865
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-3262683
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-103919
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
25034
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
32491
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
32491
Annuals > 3 > balance Sheet > payables
537446
Annuals > 3 > balance Sheet > short Term Debt
1148891
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2648837
Annuals > 3 > balance Sheet > equity
-2616346
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3375602
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
655657
Annuals > 3 > cash Flow > cash From Operations
-396693
Annuals > 3 > cash Flow > capital Expenditures
3
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
250000
Annuals > 3 > cash Flow > net Change In Cash
-146693
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.18007181850504098
Annuals > 3 > ratios > PB
-63.62433760672327
Annuals > 3 > ratios > ROE
129.0197091669068
Annuals > 3 > ratios > ROA
-10389.344741620756
Annuals > 3 > ratios > FCF
-396696
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.4484714949110557
Valuation > metrics > PB
-16.261474471126867
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
72.92807765524235
Profitability > metrics > ROA
-290.9234812815879
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-7.972553933882493
Risk > final Score
-2
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.197780886206358
Liquidity > metrics > Quick Ratio
5.197780886206358
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-65
Prev Risks > 1
-285
Prev Risks > 2
-29
Prev Liquidities > 0
32
Prev Liquidities > 1
94
Prev Liquidities > 2
41
Updated At
2026-01-20T22:18:33.203Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-14
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.4485
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-18
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.3
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-06-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.1
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.13
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.13
Earnings History > 4 > surprise Percent
-
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary brain tumors. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. NeOnc Technologies Holdings, Inc. was incorporated in 2005 and is headquartered in Calabasas, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow correlated is NTHI to the S P500 - July 2025 Snapshot & Real-Time Volume Trigger Notifications baoquankhu1.vn
Read more →Sentiment Review: Can Yum Brands Inc expand into new markets baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of NeOnc Technologies Holdings, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.4485
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.